http://www.entremed.com/Researches and develops biopharmaceutical products which address the role of blood and blood vessels in the prevention and treatment of diseases by inhibiting growth or enhancing bioavailability of drugs. Based in Rockville, Maryland. (Nasdaq: ENMD)Biopharmaceuticals > Research and DevelopmentEntreMed, Inc. (Nasdaq: ENMD)
is a clinical-stage pharmaceutical company developing a new generation of multi-mechanism drugs for the treatment
of cancer and inflammatory diseases. EntreMed's drug candidates target disease cells and the blood vessels that nourish them.
The Company's goal is to
For detailed information visit the website, please...entremedenmdpanzem2-methoxyestradiol2me2tfpitissue factor pathwaytissue factor pathway inhibitorspar-2proteinase activated receptor
Develops gene-based therapeutic products derived from adeno-associated virus for the treatment of inherited and acquired diseases. Includes explanation of technology, product pipeline, collaborative partnerships and investment data, from manufacturing facility in Alameda, California. (Nasdaq: AVGN)
Development and manufacture of recombinant proteins and peptides, in partnership with big pharmas. Includes licensing of technology derived from the host-defense protein BPI, monoclonal antibodies to treat chemotherapy-induced thrombocytopenia, and to target cancer. Based in Berkeley, California.
Researches and develops growth factor blockers and anti-cancer vaccines. Includes clinical programs, investor details and overview of company in New York City. (Nasdaq: IMCL)
Joining mailing list will entitle you
to receive occasional emails informing you of news and
updates to the site and any special offers that may be
of interest to you.